Company Profile
Surface Oncology Stock Price, News & Catalysts
- Ticker:
- SURF
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for SURF.
Company overview
Business overview
Surface Oncology was an immuno-oncology company focused on antibody-based cancer therapies before its restructuring and decline. Its platform centered on immune checkpoints and tumor biology.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ before restructuring, Surface sat in oncology biotechnology.
Business Model Characteristics
The business depended on clinical validation, platform differentiation, and the ability to create oncology value.
Position Within the Biotechnology Landscape
Surface belongs to the historical oncology-biotech category rather than the current live public-company set.
Future catalysts
- Surface Oncology is now largely a closeout story, with catalysts limited to any strategic or asset-disposition update. Investors are mainly watching what residual value can be realized.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Surface Oncology do?
Surface Oncology was an immuno-oncology company focused on antibody-based cancer therapies before its restructuring and decline. Its platform centered on immune checkpoints and tumor biology.
On which exchange is SURF stock listed?
Surface Oncology (SURF) is associated with NASDAQ, United States, Biopharma.
What is Surface?
Surface Oncology is now largely a closeout story, with catalysts limited to any strategic or asset-disposition update.
Which conditions is Surface Oncology targeting with Surface?
Surface Oncology is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Surface Oncology describe recent progress with Surface?
Surface Oncology is now largely a closeout story, with catalysts limited to any strategic or asset-disposition update.
What is Oncology?
Surface Oncology was an immuno-oncology company focused on antibody-based cancer therapies before its restructuring and decline.
What should investors watch for with Oncology?
Surface Oncology is now largely a closeout story, with catalysts limited to any strategic or asset-disposition update.
What is Investors?
Investors are mainly watching what residual value can be realized.